Bloomberg reports investors sought more concrete turnaround measures

3 Sep 21 5:29 AM · 5d ago · 1 article · 1 source · development 3 of 5

Bloomberg correspondent Sanne Wass characterized investor reaction as disappointment over the lack of concrete steps to address how Novo will replace its blockbuster Wegovy and Ozempic drugs once their patents expire in the next decade. She noted the strategy contained broad visions but lacked specific targets to impress the market, though added that more details were expected as the capital markets day continued.